ICL Group Ltd. (ICL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ICL SEC filings page.
ICL Group Ltd. (ICL) reported $7.2B in revenue for fiscal year 2025, up 4.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
ICL’s revenue recovery is not reaching profit because costs and working-capital demands are expanding faster than sales.
In FY2025, revenue rose4.6% while cost of revenue rose8.3% , pushing gross margin to30.6% and operating margin to8.1% ; this indicates cost pressure or mix deterioration rather than scale-driven expansion. Net income fell44.5% to$226M , while operating cash flow fell28.1% to$1.056B , so cash generation weakened less sharply than accounting profit but still deteriorated.
The balance sheet is becoming more working-capital-led than debt-led: long-term debt fell
Operating cash flow was
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of ICL Group Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
ICL Group Ltd. has an operating margin of 8.1%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 61/100, indicating healthy but not exceptional operating efficiency. This is down from 11.3% the prior year.
ICL Group Ltd.'s revenue grew a modest 4.6% year-over-year to $7.2B. This slow but positive growth earns a score of 22/100.
ICL Group Ltd. has a moderate D/E ratio of 0.31. This balance of debt and equity financing earns a leverage score of 41/100.
ICL Group Ltd.'s current ratio of 1.33 indicates adequate short-term liquidity, earning a score of 35/100. The company can meet its near-term obligations, though with limited headroom.
Not available for ICL Group Ltd., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.
ICL Group Ltd.'s ROE of 3.8% shows moderate profitability relative to equity, earning a score of 55/100. This is down from 7.1% the prior year.
ICL Group Ltd. passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, ICL Group Ltd. generates $4.67 in operating cash flow ($1.1B OCF vs $226.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
ICL Group Ltd. earns $4.96 in operating income for every $1 of interest expense ($580.0M vs $117.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
ICL Group Ltd. generated $7.2B in revenue in fiscal year 2025. This represents an increase of 4.6% from the prior year.
ICL Group Ltd.'s EBITDA was $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 12.8% from the prior year.
ICL Group Ltd. reported $226.0M in net income in fiscal year 2025. This represents a decrease of 44.5% from the prior year.
ICL Group Ltd. earned $0.18 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 43.8% from the prior year.
Cash & Balance Sheet
ICL Group Ltd. held $291.0M in cash against $1.9B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
ICL Group Ltd.'s gross margin was 30.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.4 percentage points from the prior year.
ICL Group Ltd.'s operating margin was 8.1% in fiscal year 2025, reflecting core business profitability. This is down 3.2 percentage points from the prior year.
ICL Group Ltd.'s net profit margin was 3.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.8 percentage points from the prior year.
ICL Group Ltd.'s ROE was 3.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.3 percentage points from the prior year.
Capital Allocation
ICL Group Ltd. invested $70.0M in research and development in fiscal year 2025. This represents an increase of 1.4% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
ICL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B+4.6% | $6.8B-9.2% | $7.5B-24.8% | $10.0B+44.0% | $7.0B+37.9% | $5.0B-4.3% | $5.3B-5.1% | $5.6B+2.5% | $5.4B+1.0% | $5.4B-0.8% | $5.4B |
| Cost of Revenue | $5.0B+8.3% | $4.6B-5.8% | $4.9B-2.4% | $5.0B+14.7% | $4.3B+22.3% | $3.6B+2.9% | $3.5B-6.7% | $3.7B-1.2% | $3.7B+1.2% | $3.7B+2.8% | $3.6B |
| Gross Profit | $2.2B-3.1% | $2.3B-15.5% | $2.7B-46.9% | $5.0B+92.7% | $2.6B+75.2% | $1.5B-18.0% | $1.8B-2.0% | $1.9B+10.9% | $1.7B+0.7% | $1.7B-7.9% | $1.8B |
| R&D Expenses | $70.0M+1.4% | $69.0M-2.8% | $71.0M+4.4% | $68.0M+6.3% | $64.0M+18.5% | $54.0M+8.0% | $50.0M-9.1% | $55.0M0.0% | $55.0M-24.7% | $73.0M-1.4% | $74.0M |
| Operating Income | $580.0M-25.2% | $775.0M-32.1% | $1.1B-67.5% | $3.5B+190.6% | $1.2B+499.0% | $202.0M-73.3% | $756.0M-50.2% | $1.5B+141.5% | $629.0Mn/m | -$3.0M-100.4% | $765.0M |
| EBITDA | $1.2B-12.8% | $1.4B-18.2% | $1.7B-58.2% | $4.0B+136.1% | $1.7B+146.0% | $691.0M-42.4% | $1.2B-37.6% | $1.9B+88.6% | $1.0B+156.0% | $398.0M-64.5% | $1.1B |
| Interest Expense | $117.0M-4.1% | $122.0M-2.4% | $125.0M+10.6% | $113.0M+0.9% | $112.0M+2.8% | $109.0Mn/m | -$115.0Mn/m | -$103.0M-192.8% | $111.0M-0.9% | $112.0M+28.7% | $87.0M |
| Income Tax | $161.0M-6.4% | $172.0M-40.1% | $287.0M-75.8% | $1.2B+355.8% | $260.0M+940.0% | $25.0M-83.0% | $147.0M+14.0% | $129.0M-18.4% | $158.0M+187.3% | $55.0M-66.0% | $162.0M |
| Net Income | $226.0M-44.5% | $407.0M-37.1% | $647.0M-70.0% | $2.2B+175.7% | $783.0M+7018.2% | $11.0M-97.7% | $475.0M-61.7% | $1.2B+240.7% | $364.0Mn/m | -$122.0M-124.0% | $509.0M |
| EPS (Basic) | $0.18-43.8% | $0.32-36.0% | $0.50-70.2% | $1.68+175.4% | $0.61+6000.0% | $0.01-97.3% | $0.37-61.9% | $0.97+234.5% | $0.29n/m | -$0.10-125.0% | $0.40 |
| EPS (Diluted) | $0.18-43.8% | $0.32-36.0% | $0.50-70.1% | $1.67+178.3% | $0.60+5900.0% | $0.01-97.3% | $0.37-61.9% | $0.97+234.5% | $0.29n/m | -$0.10-125.0% | $0.40 |
| Diluted Shares (Avg) | 1.29B+0.1% | 1.29B0.0% | 1.29B+0.1% | 1.29B+0.2% | 1.29B+0.5% | 1.28B-0.1% | 1.28B+0.2% | 1.28B+0.2% | 1.28B+0.3% | 1.27B+0.1% | 1.27B |
Not reported in any period shown, so not listed: SG&A Expenses.
ICL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.4B+9.6% | $11.3B-2.6% | $11.6B-1.0% | $11.8B+6.0% | $11.1B+14.7% | $9.7B+5.4% | $9.2B+4.5% | $8.8B+0.7% | $8.7B+1.9% | $8.6B | N/A |
| Current Assets | $4.2B+16.1% | $3.6B-11.1% | $4.0B-11.3% | $4.5B+16.3% | $3.9B+37.6% | $2.8B+5.8% | $2.7B-3.7% | $2.8B+2.3% | $2.7B+6.0% | $2.6B | N/A |
| Cash & Equivalents | $291.0M-11.0% | $327.0M-22.1% | $420.0M+0.7% | $417.0M-11.8% | $473.0M+121.0% | $214.0M+125.3% | $95.0M-21.5% | $121.0M+45.8% | $83.0M-4.6% | $87.0M-46.0% | $161.0M |
| Inventory | $1.9B+18.9% | $1.6B-4.5% | $1.7B-20.2% | $2.1B+35.9% | $1.6B+25.6% | $1.3B-4.7% | $1.3B+1.7% | $1.3B+5.2% | $1.2B-3.2% | $1.3B | N/A |
| Goodwill | $955.0M+9.9% | $869.0M-0.5% | $873.0M+2.5% | $852.0M-1.7% | $867.0M+29.4% | $670.0M+2.8% | $652.0M-2.8% | $671.0M-7.1% | $722.0M-12.4% | $824.0M | N/A |
| Total Liabilities | $6.2B+15.7% | $5.3B-4.6% | $5.6B-7.4% | $6.0B-4.8% | $6.3B+13.8% | $5.6B+9.1% | $5.1B+5.2% | $4.9B-16.0% | $5.8B-1.8% | $5.9B | N/A |
| Current Liabilities | $3.1B+34.5% | $2.3B-11.8% | $2.6B+1.2% | $2.6B-0.2% | $2.6B+20.0% | $2.2B+23.6% | $1.8B-12.3% | $2.0B-13.7% | $2.3B+15.1% | $2.0B | N/A |
| Non-Current Liabilities | $3.0B+1.1% | $3.0B+1.8% | $3.0B-14.0% | $3.4B-8.1% | $3.7B+9.8% | $3.4B+1.4% | $3.4B+17.5% | $2.9B-17.5% | $3.5B-10.7% | $3.9B | N/A |
| Long-Term Debt | $1.9B-1.5% | $1.9B+4.4% | $1.8B-20.9% | $2.3B-5.1% | $2.4B+18.7% | $2.1B-5.9% | $2.2B+20.2% | $1.8B-24.0% | $2.4B-14.6% | $2.8B | N/A |
| Total Equity | $6.0B+4.5% | $5.7B-0.8% | $5.8B+5.6% | $5.5B+20.7% | $4.5B+15.2% | $3.9B+0.1% | $3.9B+3.8% | $3.8B+32.2% | $2.9B+11.1% | $2.6B-19.3% | $3.2B |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments, Retained Earnings.
ICL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B-28.1% | $1.5B-14.2% | $1.7B-19.8% | $2.1B+100.1% | $1.1B+32.5% | $804.0M-19.0% | $992.0M+60.0% | $620.0M-26.8% | $847.0M-12.3% | $966.0M+68.6% | $573.0M |
| Depreciation & Amortization | $615.0M+3.2% | $596.0M+11.2% | $536.0M+7.6% | $498.0M+1.6% | $490.0M+0.2% | $489.0M+10.4% | $443.0M+9.9% | $403.0M+3.3% | $390.0M-2.7% | $401.0M+13.0% | $355.0M |
| Investing Cash Flow | -$915.0Mn/m | -$694.0Mn/m | -$853.0Mn/m | -$747.0Mn/m | -$579.0Mn/m | -$583.0Mn/m | -$525.0M-258.6% | $331.0Mn/m | -$333.0Mn/m | -$800.0Mn/m | -$547.0M |
| Financing Cash Flow | -$195.0Mn/m | -$846.0Mn/m | -$837.0Mn/m | -$1.4Bn/m | -$244.0Mn/m | -$105.0Mn/m | -$490.0Mn/m | -$894.0Mn/m | -$511.0Mn/m | -$239.0M-1693.3% | $15.0M |
| Dividends Paid | $224.0M-10.8% | $251.0M-47.0% | $474.0M-59.3% | $1.2B+322.5% | $276.0M+133.9% | $118.0M-56.8% | $273.0M+13.3% | $241.0M+1.7% | $237.0M+46.3% | $162.0M-53.3% | $347.0M |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.
ICL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.6%-2.4pp | 33.0%-2.5pp | 35.4%-14.8pp | 50.2%+12.7pp | 37.5%+8.0pp | 29.5%-4.9pp | 34.5%+1.1pp | 33.4%+2.5pp | 30.9%-0.1pp | 30.9%-2.4pp | 33.4% |
| Operating Margin | 8.1%-3.2pp | 11.3%-3.8pp | 15.1%-20.0pp | 35.1%+17.7pp | 17.4%+13.4pp | 4.0%-10.3pp | 14.3%-13.0pp | 27.3%+15.7pp | 11.6%+11.7pp | -0.1%-14.2pp | 14.1% |
| Net Margin | 3.2%-2.8pp | 5.9%-2.6pp | 8.6%-13.0pp | 21.6%+10.3pp | 11.3%+11.0pp | 0.2%-8.8pp | 9.0%-13.3pp | 22.3%+15.6pp | 6.7%+9.0pp | -2.3%-11.7pp | 9.4% |
| Return on Equity | 3.8%-3.3pp | 7.1%-4.1pp | 11.2%-28.3pp | 39.5%+22.2pp | 17.3%+17.0pp | 0.3%-11.8pp | 12.1%-20.7pp | 32.8%+20.1pp | 12.7%+17.5pp | -4.7%-20.7pp | 16.0% |
| Return on Assets | 1.8%-1.8pp | 3.6%-2.0pp | 5.6%-12.8pp | 18.4%+11.3pp | 7.1%+7.0pp | 0.1%-5.1pp | 5.2%-9.0pp | 14.1%+10.0pp | 4.2%+5.6pp | -1.4% | N/A |
| Current Ratio | 1.33-0.2x | 1.540.0x | 1.53-0.2x | 1.75+0.2x | 1.50+0.2x | 1.30-0.2x | 1.52+0.1x | 1.39+0.2x | 1.17-0.1x | 1.27 | N/A |
| Debt-to-Equity | 0.310.0x | 0.330.0x | 0.32-0.1x | 0.42-0.1x | 0.540.0x | 0.520.0x | 0.56+0.1x | 0.48-0.4x | 0.84-0.3x | 1.09 | N/A |
| Liabilities-to-Equity | 1.03+0.1x | 0.930.0x | 0.97-0.1x | 1.10-0.3x | 1.400.0x | 1.42+0.1x | 1.300.0x | 1.29-0.7x | 2.02-0.3x | 2.29 | N/A |
| Asset Turnover | 0.580.0x | 0.600.0x | 0.65-0.2x | 0.85+0.2x | 0.63+0.1x | 0.52-0.1x | 0.57-0.1x | 0.630.0x | 0.620.0x | 0.63 | N/A |
Not reported in any period shown, so not listed: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| ICL Group Ltd. ICL | FY2025 | $7.2B | $226.0M | 3.2% | $6.2B | 43/100 |
| FMC Corporation FMC | FY2025 | $3.5B | -$2.2B | -64.6% | $785.5M | 23/100 |
| The Scotts Miracle-Gro Company SMG | FY2025 | $3.4B | $145.2M | 4.3% | $3.5B | 37/100 |
| The Mosaic Company MOS | FY2025 | $12.1B | $540.7M | 4.5% | $5.7B | 34/100 |
| CF Industries Holding, Inc. CF | FY2025 | $7.1B | $1.5B | 20.5% | $18.3B | 74/100 |
| Nutrien Ltd. NTR | FY2025 | $26.9B | $2.3B | 8.4% | $33.3B | 45/100 |
Where ICL Group Ltd. Ranks
Frequently Asked Questions
What is ICL Group Ltd.'s annual revenue?
ICL Group Ltd. (ICL) reported $7.2B in total revenue for fiscal year 2025. This represents a 4.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ICL Group Ltd.'s revenue growing?
ICL Group Ltd. (ICL) revenue grew by 4.6% year-over-year, from $6.8B to $7.2B in fiscal year 2025.
Is ICL Group Ltd. profitable?
Yes, ICL Group Ltd. (ICL) reported a net income of $226.0M in fiscal year 2025, with a net profit margin of 3.2%.
What is ICL Group Ltd.'s EBITDA?
ICL Group Ltd. (ICL) had EBITDA of $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does ICL Group Ltd. have?
As of fiscal year 2025, ICL Group Ltd. (ICL) had $291.0M in cash and equivalents against $1.9B in long-term debt.
What is ICL Group Ltd.'s gross margin?
ICL Group Ltd. (ICL) had a gross margin of 30.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is ICL Group Ltd.'s operating margin?
ICL Group Ltd. (ICL) had an operating margin of 8.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is ICL Group Ltd.'s net profit margin?
ICL Group Ltd. (ICL) had a net profit margin of 3.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ICL Group Ltd.'s return on equity (ROE)?
ICL Group Ltd. (ICL) has a return on equity of 3.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ICL Group Ltd.'s operating cash flow?
ICL Group Ltd. (ICL) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ICL Group Ltd.'s total assets?
ICL Group Ltd. (ICL) had $12.4B in total assets as of fiscal year 2025, including both current and long-term assets.
How much does ICL Group Ltd. spend on research and development?
ICL Group Ltd. (ICL) invested $70.0M in research and development during fiscal year 2025.
What is ICL Group Ltd.'s current ratio?
ICL Group Ltd. (ICL) had a current ratio of 1.33 as of fiscal year 2025, which is considered adequate.
What is ICL Group Ltd.'s debt-to-equity ratio?
ICL Group Ltd. (ICL) had a debt-to-equity ratio of 0.31 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is ICL Group Ltd.'s liabilities-to-equity ratio?
ICL Group Ltd. (ICL) had a liabilities-to-equity ratio of 1.03 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is ICL Group Ltd.'s return on assets (ROA)?
ICL Group Ltd. (ICL) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ICL Group Ltd.'s P/E ratio?
ICL Group Ltd. (ICL) trades at 27.2x earnings, its market capitalization divided by $226.0M net income, FY2025. The market capitalization is $6.2B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ICL Group Ltd.'s price-to-sales ratio?
ICL Group Ltd. (ICL) trades at 0.9x sales, its market capitalization divided by $7.2B revenue, FY2025. The market capitalization is $6.2B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ICL Group Ltd.'s Piotroski F-Score?
ICL Group Ltd. (ICL) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ICL Group Ltd.'s earnings high quality?
ICL Group Ltd. (ICL) has an earnings quality ratio of 4.67x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can ICL Group Ltd. cover its interest payments?
ICL Group Ltd. (ICL) has an interest coverage ratio of 4.96x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is ICL Group Ltd.?
ICL Group Ltd. (ICL) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For ICL Group Ltd. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.